-
Aug 04, 2021 04:37 PM IST Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 844 in its research report dated July 28, 2021.
-
Feb 01, 2021 06:12 PM IST Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 848 in its research report dated January 27, 2021.
- Nov 04, 2020 08:54 PM IST
Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 813 in its research report dated October 28, 2020.
- Jul 30, 2020 06:43 PM IST
Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 2090 in its research report dated July 28, 2020.
- May 20, 2020 04:21 PM IST
Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 1028 in its research report dated May 19, 2020.
- Nov 23, 2018 11:45 AM IST
Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 745 in its research report dated November 21, 2018.
- Oct 04, 2018 05:01 PM IST
Centrum is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 910 in its research report dated October 04, 2018.
- May 23, 2018 03:44 PM IST
Centrum is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 960 in its research report dated May 17, 2018.
- Jan 15, 2018 05:51 PM IST
Centrum Research is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 940 in its research report dated January 15, 2018.
- Feb 10, 2016 03:33 PM IST
Motilal Oswal is bullish on Suprajit Eng has recommended buy rating on the stock with a target price of Rs 705 in its research report dated Februrary 10, 2016.
- Aug 05, 2015 11:50 AM IST
Brokerage house Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target price of Rs 790 in its research report dated August 3, 2015.
- Jan 10, 2014 04:14 PM IST
Brokerage house Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target price of Rs 240 in its January 06, 2014 research report.
- Jun 26, 2013 04:00 PM IST
Sunidhi Securities is bullish on Aarti Drugs (ADL) and has recommended buy rating on the stock with a price target of Rs 260 in its June 26, 2013 research report.
- Apr 10, 2013 12:49 PM IST
Sunidhi Securities is bullish on Aarti Drugs and has recommended buy rating on the stock with a target of Rs 210 in its April 09, 2013 research report.
- Apr 08, 2013 12:11 PM IST
Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target of Rs 175 in its April 4, 2013 research report.
